» Articles » PMID: 26861722

Placental Findings Associated with Maternal Obesity at Early Pregnancy

Overview
Specialty Pathology
Date 2016 Feb 11
PMID 26861722
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Obesity during pregnancy is associated with a wide spectrum of maternal, fetal and neonatal complications. This study compared placental pathology in women with obesity and normal weight gravidas.

Materials And Methods: This is a retrospective case-control study. The sample was randomly selected from a total of 1000 deliveries of largely Caucasian population in a single institution, recruited for the study of sleep disordered breathing, where the placenta is submitted for pathological examination for clinical indications based on national guidelines. Cases (Body mass index - BMI ≥ 30 kg/m(2); n = 47) and controls (BMI < 25 kg/m(2), n = 45) were selected based on BMI obtained from the first prenatal visit. Placental pathology, clinical parameters and limited outcomes were extracted from medical records. Placental weight range was defined as small for gestational age (SGA) if < 10th percentile, large for gestational age (LGA) if > 90th percentile.

Results: Mean BMI was 36.2 ± 5.5 in the group with obesity and 21.7 ± 1.9 in the control group (p < 0.01). There was a significantly higher prevalence of diabetes in cases compared to controls (14/47 vs. 3/45, p = 0.006) while preterm birth was significantly higher in the control group (9/47 vs. 19/46, p = 0.02). There were more LGA placentas in cases versus controls (12/47 vs. 2/46, p = 0.007; even after adjusting for diabetes). More histological features of inflammation, marginal insertion of the umbilical cord and intervillous thrombi in the parenchyma were also noted in the case group.

Conclusions: Results from the current study suggest that maternal obesity measured at early pregnancy may have effects on both placental implantation and growth, and further exacerbate the hypercoagulable state in placenta.

Citing Articles

Gestational Age, Infection, and Suboptimal Maternal Prepregnancy BMI Independently Associate with Placental Histopathology in a Cohort of Pregnancies without Major Maternal Comorbidities.

Duffley E, Grynspan D, Scott H, Lafreniere A, Borba Vieira DE Andrade C, Bloise E J Clin Med. 2024; 13(12).

PMID: 38929907 PMC: 11204067. DOI: 10.3390/jcm13123378.


Higher Maternal Body Mass Index Is Associated With Lower Placental Expression of EPYC: A Genome-Wide Transcriptomic Study.

Sordillo J, White F, Majid S, Aguet F, Ardlie K, Karumanchi S J Clin Endocrinol Metab. 2023; 109(3):e1159-e1166.

PMID: 37864851 PMC: 10876411. DOI: 10.1210/clinem/dgad619.


Prepregnancy obesity and risk of placental inflammation at term: a selection bias analysis.

Layden A, Bertolet M, Parks W, Adibi J, Roberts J, Catov J Ann Epidemiol. 2023; 86:25-33.e7.

PMID: 37302673 PMC: 10546767. DOI: 10.1016/j.annepidem.2023.06.003.


Impact of Co-Occurrence of Obesity and SARS-CoV-2 Infection during Pregnancy on Placental Pathologies and Adverse Birth Outcomes: A Systematic Review and Narrative Synthesis.

Ferraz T, Benton S, Zareef I, Aribaloye O, Bloise E, Connor K Pathogens. 2023; 12(4).

PMID: 37111410 PMC: 10140965. DOI: 10.3390/pathogens12040524.


Dietary soy prevents fetal demise, intrauterine growth restriction, craniofacial dysmorphic features, and impairments in placentation linked to gestational alcohol exposure: Pivotal role of insulin and insulin-like growth factor signaling networks.

Qi W, Gundogan F, Gilligan J, de la Monte S Alcohol. 2023; 110:65-81.

PMID: 36898643 PMC: 10272094. DOI: 10.1016/j.alcohol.2023.01.006.